bioventus
-
Financial
Additional Strategic Funding for CartiHeal’s Ongoing AGILI-C™ IDE Clinical Study $2.5M boost by Bioventus brings latest investment round to $21M
KFAR SABA, ISRAEL and DURHAM, NC– January 31, 2018 CartiHeal, developer of the proprietary Agili-C implant for the treatment of…
Read More » -
Biologics
Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN®
September 13, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologics, today announced the first patients have been enrolled in…
Read More » -
Biologics
Bioventus Receives US FDA Approval for DUROLANE®
September 05, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has received US FDA approval…
Read More » -
Biologics
Bioventus Names Greg Anglum Senior V.P and CFO, Tony D’Adamio Senior V.P and General Counsel
August 07, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus®, a leader in orthobiologic solutions, today announced two changes to its executive leadership team. Greg…
Read More » -
Biologics
Bioventus Expands EXOGEN® Performance Program in Canada to Include All Fracture Types
July 17, 2017 MISSISSAUGA, Ontario–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologics, today announced it has expanded the Performance Program* for its EXOGEN…
Read More » -
Biologics
Bioventus Names David Varner Vice President of Marketing, Active Healing Therapies
April 24, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has named David Varner as…
Read More » -
Biologics
Bioventus to Invest in New Clinical Research for EXOGEN®
March 15, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologics, today announced it will commission an innovative series of…
Read More » -
Biologics
Bioventus Presents Bone Healing, Osteoarthritis Pain and Bone Graft Solutions at AAOS
SAN DIEGO – March 14, 2017 – Bioventus, a leader in orthobiologic solutions, today announced its plans for the Annual…
Read More » -
Financial
Bioventus Raises $10,000 for Opportunity Village
February 13, 2017 LAS VEGAS–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, announced it raised $10,000 for Opportunity Village. More…
Read More » -
Biologics
Bioventus Shares 2017 Science Summit Schedule, Enhancements to Bioventus Academy
January 30, 2017 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologics, today announced the dates of its 2017 Advances in…
Read More » -
Biologics
Bioventus Names John Nosenzo Chief Commercial Officer
January 23, 2017 DURHAM, N.C.–(BUSINESS WIRE)– Bioventus, a global leader in orthobiologic solutions, today announced that it has named John…
Read More » -
Biologics
Bioventus Selects MEDSERVICE to Distribute DUROLANE® in Russia
January 17, 2017 HOOFDDORP, The Netherlands–(BUSINESS WIRE)–Bioventus, a leader in orthobiologic solutions, announced it has selected MEDSERVICE to distribute DUROLANE®…
Read More » -
Biologics
Bioventus Enters Into New Agreement for DUROLANE®
December 14, 2016 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologic solutions, today announced it has a new agreement with…
Read More » -
Biologics
Design Evolution of EXOGEN® Enhances Patient Compliance
December 05, 2016 DURHAM, N.C.–(BUSINESS WIRE)–Bioventus, a global leader in orthobiologics, today announced that a published study reveals its latest…
Read More »